Prostate cancer is one of the most frequently diagnosed malignancies in developed
countries and approximately 248,530 new cases of prostate cancer are likely to be …

Importance Multiple strategies integrating magnetic resonance imaging (MRI) and clinical
data have been proposed to determine the need for a prostate biopsy in men with suspected …

Background In validation studies, risk models for clinically significant prostate cancer
(csPCa; Gleason score≥ 3+ 4) combining multiparametric MRI and clinical factors have …

Abstract Background Prostate cancer (PCa)(early) detection poses significant challenges,
including unnecessary testing and the risk of potential overdiagnosis. The European …

Importance Magnetic resonance imaging (MRI)–based risk calculators can replace or
augment traditional prostate cancer (PCa) risk prediction tools. However, few data are …

Objectives We aimed to develop and compare strategies that help optimize current prostate
biopsy practice by identifying patients who may forgo concurrent systematic biopsy (SBx) in …

Simple Summary Magnetic resonance imaging (MRI) has allowed the early detection of PCa
to evolve towards clinically significant PCa (csPCa), decreasing unnecessary prostate …

Background A new generation of risk calculators (RCs) for prostate cancer (PCa)
incorporating magnetic resonance imaging (MRI) data have been introduced. However …

Objective To externally validate and compare the performance of the European Randomized
Study of Screening for Prostate Cancer risk calculator 3/4 (ERSPC‐RC3/4), the Prostate …

Background Magnetic resonance imaging (MRI) is useful in the diagnosis of clinically
significant prostate cancer (csPCa). MRI-derived radiomics may support the diagnosis of …